Inhibition of PD-1 protein by the CRISPR-Cas9 method as antitumor therapy of non-small cell lung cancers
Lung carcinoma is the second most common type of tumor in the world. Among them, 85% of the cases are of non-small cell lung cancer (NSCLC). It is known that, in general, NSCLC tumor cells proliferate due to a reduction in the cytotoxic T lymphocyte response. In the immune response to tumors, the in...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | Portuguese |
| Published: |
Pontifícia Universidade Católica de São Paulo
2019-06-01
|
| Series: | Revista da Faculdade de Ciências Médicas de Sorocaba |
| Subjects: | |
| Online Access: | http://revistas.pucsp.br/RFCMS/article/view/38943 |